[
    "{\"step_by_step_thinking\": \"Enlimomab is a monoclonal antibody that targets the inflammatory response in the brain. To determine if it can improve stroke outcomes, we need to consider the available evidence. The effectiveness of Enlimomab in improving stroke outcomes has been studied in clinical trials. We should review the results of these trials to make an informed decision.\", \"answer_choice\": \"B. no\"}"
]